ArticleInternational journal of hematology2020

Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis.

Kazuhito Suzuki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.